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Editorial
Ten reasons to conduct a randomized 
study in quality improvement
In the years 2004–06, the Journal has published 192 papers
(excluding editorials and letters) of which eight (4.2%) were
randomized experiments [1–8]. Four per cent is not enough,
considering that randomization is the most direct path to a
causal inference. To be effective, we need to understand what
causes what in quality improvement. This aim is not compati-
ble with weak research methods. Some quality experts claim
that the evaluation of quality projects requires less scientific
rigour than ‘academic’ research. It their view, small uncon-
trolled before/after studies or even spontaneous experiential
learning is sufficient. How could that be possible? Quality
improvement deals with complex systems, multifactorial
interventions, unpredictable individuals, and multifaceted
outcomes. If the object of inquiry is complex, the research
methods must be clever and imaginative, but also rigorous.
But I digress. The bottom line is: we need more randomized
studies in the field of quality improvement. Here are some
reasons why you should consider performing one.
1. Randomized studies are simple and elegant
People have the notion that randomized studies are compli-
cated, whereas observational studies are nice and simple. It is
the other way around. Whatever intervention you allocate ran-
domly will reveal its effect, or lack thereof, without artefacts
(which, granted, may not be the desired outcome on occasion).
By contrast, the interpretation of an observational study will
require a lot of thinking about possible confounders and a long
‘limitations’ section when you write up the findings.
2. You can focus on the important variables
Because you will not have to worry about confounding var-
iables, you will not have to measure them. There is a neces-
sary trade-off between the quantity and the quality of
information that can be collected in any study. In a rand-
omized trial, you can focus on a short list of key variables,
measure them with all the necessary precision, and still have a
manageable dataset.
3. You can do the statistical analysis yourself
Another beauty of a randomized experiment is that the
main analysis is extremely simple: it is a head-to-head compar-
ison of two (or more) groups. If you can do a chi-squared test
on a 2 × 2 table, or run a t-test, you will be fine most of the
time (to be honest, true statistical expertise will be necessary
at times, as in the case of cluster randomization, repeated
measurements, many missing observations, etc.).
4. It is alright if the intervention is complex
The paradigm of a randomized clinical trial, the pharmaceuti-
cal phase III trial, usually examines a simplistic intervention—an
antibiotic for an infection, an antidepressant for depression, etc.
However, the randomized design works just as well with
complex interventions. Diagnostic strategies, strategies of dif-
fusion of innovations, and public health programmes—for
any of these, the key question is ‘does it work better than
usual care’, and all can be tested in randomized trials. You
may not be able to say what component of a quality improve-
ment intervention was the most critical, but that is not the
most relevant question in real life. These ‘pragmatic’ rand-
omized trials are much underused [9,10].
5. Blinding and placebos are not always necessary
Most pragmatic trials do not require placebos or blinding.
The placebo effect is part and parcel of any intervention that
aims for systemic change. People have to be motivated to
work differently. Hiding the fact that change is underway does
not make sense. Another reason for having a placebo is to
allow blinding, i.e. an unbiased assessment of effects. There
are other ways of achieving this aim: reliance on validated
instruments, separation of the roles of assessor and promoter
of the intervention, or use of routinely collected outcome data.
6. Many things can be randomized
We usually think of randomizing patients, but this was
done in only one of the eight trials published in this journal
[4]. Random allocation of health care providers—doctors,
hospitals, etc.—is often the appropriate approach for quality
improvement interventions [3,5,6]. Alternatively, within an
organization, time-periods can be randomly allocated to an
active or a control intervention, in the manner of N-of-1 clin-
ical trials. Moreover, randomized experiments can be per-
formed to compare feedback methods for policy makers [1],
perceptions of medical errors by the public [2], survey meth-
ods [8], or the usability of medical devices [7].
7. You will be a better researcher
Because an observational study does not interfere with
practice, observational research makes things a bit too easy
for the researcher and hence encourages sloppiness. Measure
a lot of variables, cross-tabulate them back and forth, and
eventually something will pop up that will be interesting. By
contrast, when you randomize, you have to think hard about
what the key scientific question is—you only get that one
chance. And you have to commit to that research question in
writing. But the hard thinking at the start of the project pays
off eventually in the relevance of the results.
8. You will get published easily
It is unusual to perform a randomized study and not be able to
publish the results rapidly and in a reputable journal. You get
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instant credibility with editors and reviewers by randomizing. No
reviewer of your manuscript will be able to write in all impunity:
‘this association may be due to unmeasured confounders’—the
kiss of death of an observational study, because by definition
what you have not measured you cannot adjust for.
9. You may win the Reizenstein prize
The Reizenstein prize rewards the best paper published in
the International Journal for Quality in Health Care of the previous
year. It is awarded based on the votes of the members of the
journal’s editorial board. Two of the last three laureate papers
were based on a randomized design [2,5]. Thus, the risk of
winning the prize is 25% (2 of 8) if your study is randomized,
and 0.5% (1 of 184) if it is not—a relative risk of 50. But then
again, we did not randomly allocate these studies to be rand-
omized or not....
10. You will have fun
Performing your first randomized trial will be exhilarating,
like the first time you could ride a bicycle. Take off these
training wheels!
Thomas Perneger
Quality of Care Service, University Hospitals
of Geneva, Geneva, Switzerland
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